Open AccessDEVELOPMENT OF A NEW STRATEGY FOR MINIMIZING ISLET CELL MASS IN TYPE 1 DIABETIC RECIPIENTS: DIANNEXIN REDUCES PROAPOPTOTIC BID, PROMOTES ANTI-INFLAMMATORY INTERLEUKIN-10 AND IMPROVES EARLY GRAFT FUNCTION IN THE MARGINAL ISLET MASS TRANSPLANTATION MODEL
Author(s) -
Elaine Cheng,
Hua Yang,
Vijay Kumar Sharma,
Milagros Lagman,
David B. Leeser,
Manikkam Suthanthiran
Publication year - 2010
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-201007272-00684
Subject(s) - islet , type 1 diabetes , medicine , function (biology) , interleukin , inflammation , immunology , apoptosis , diabetes mellitus , cytokine , endocrinology , microbiology and biotechnology , biology , biochemistry